Black Diamond Therapeutics Inc

NASDAQ:BDTX   3:59:51 PM EDT
9.28
-0.35 (-3.63%)
Earnings Announcements

Black Diamond Therapeutics Reports Quarterly Loss Per Share Of $0.95

Published: 08/12/2021 12:45 GMT
Black Diamond Therapeutics Inc (BDTX) - Black Diamond Therapeutics Inc - Qtrly Loss per Share $0.95.
Black Diamond Therapeutics Inc - Cash, Cash Equivalents of $263.5 Million As of June 30, 2021, Expected to Be Sufficient to Fund Operations Into 2023.
Further Company Coverage: Bdtxo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.96

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.99

More details on our Analysts Page.